These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
1674 related articles for article (PubMed ID: 16674999)
21. Unfractionated and low-molecular-weight heparin as adjuncts to thrombolysis in aspirin-treated patients with ST-elevation acute myocardial infarction: a meta-analysis of the randomized trials. Eikelboom JW; Quinlan DJ; Mehta SR; Turpie AG; Menown IB; Yusuf S Circulation; 2005 Dec; 112(25):3855-67. PubMed ID: 16344381 [TBL] [Abstract][Full Text] [Related]
22. Subcutaneous adjusted-dose unfractionated heparin vs fixed-dose low-molecular-weight heparin in the initial treatment of venous thromboembolism. Prandoni P; Carnovali M; Marchiori A; Arch Intern Med; 2004 May; 164(10):1077-83. PubMed ID: 15159264 [TBL] [Abstract][Full Text] [Related]
23. Low molecular weight heparin for the prevention of venous thromboembolism after abdominal surgery. Bergqvist D Br J Surg; 2004 Aug; 91(8):965-74. PubMed ID: 15286956 [TBL] [Abstract][Full Text] [Related]
24. Efficacy of extended thrombo-prophylaxis in major abdominal surgery: what does the evidence show? A meta-analysis. Bottaro FJ; Elizondo MC; Doti C; Bruetman JE; Perez Moreno PD; Bullorsky EO; Ceresetto JM Thromb Haemost; 2008 Jun; 99(6):1104-11. PubMed ID: 18521515 [TBL] [Abstract][Full Text] [Related]
25. Intravenous low-molecular-weight heparins compared with unfractionated heparin in percutaneous coronary intervention: quantitative review of randomized trials. Dumaine R; Borentain M; Bertel O; Bode C; Gallo R; White HD; Collet JP; Steinhubl SR; Montalescot G Arch Intern Med; 2007 Dec; 167(22):2423-30. PubMed ID: 18071163 [TBL] [Abstract][Full Text] [Related]
26. Low molecular weight heparin and compression stockings in the prevention of venous thromboembolism in neurosurgery. Nurmohamed MT; van Riel AM; Henkens CM; Koopman MM; Que GT; d'Azemar P; Büller HR; ten Cate JW; Hoek JA; van der Meer J; van der Heul C; Turpie AG; Haley S; Sicurella A; Gent M Thromb Haemost; 1996 Feb; 75(2):233-8. PubMed ID: 8815566 [TBL] [Abstract][Full Text] [Related]
27. Cost implications of low molecular weight heparins as prophylaxis following total hip and knee replacement. Bell GK; Goldhaber SZ Vasc Med; 2001; 6(1):23-9. PubMed ID: 11358156 [TBL] [Abstract][Full Text] [Related]
28. [Treatment of venous thrombosis in cancer patients: practical aspects]. Laza-Achille M; Desruennes E; Di Palma M Bull Cancer; 2006 Mar; 93(3):271-81. PubMed ID: 16567314 [TBL] [Abstract][Full Text] [Related]
29. Home treatment of deep venous thrombosis with low molecular weight heparin: Long-term incidence of recurrent venous thromboembolism. Grau E; Tenias JM; Real E; Medrano J; Ferrer R; Pastor E; Selfa S Am J Hematol; 2001 May; 67(1):10-4. PubMed ID: 11279651 [TBL] [Abstract][Full Text] [Related]
30. Reviparin sodium clivarine: a review of its therapeutic use. Gore M; Kelkar P; Rege N; Ross C J Indian Med Assoc; 2004 Oct; 102(10):589-90, 592. PubMed ID: 15887830 [TBL] [Abstract][Full Text] [Related]
31. A fixed-dose combination of low molecular weight heparin with dihydroergotamine versus adjusted-dose unfractionated heparin in the prevention of deep-vein thrombosis after total hip replacement. Horbach T; Wolf H; Michaelis HC; Wagner W; Hoffmann A; Schmidt A; Beck H Thromb Haemost; 1996 Feb; 75(2):246-50. PubMed ID: 8815569 [TBL] [Abstract][Full Text] [Related]
32. Suboptimal doses of low molecular weight heparin and acute venous thromboembolism. Data from the RIETE registry. Bruscas MJ; Nieto JA; Perez-Pinar M; López-Jiménez L; Fernández-Capitán C; López-Chuliá F; Orue-Lecue MT; Ann Hematol; 2007 Jul; 86(7):519-26. PubMed ID: 17437112 [TBL] [Abstract][Full Text] [Related]
33. The management of thrombosis in pregnancy: role of low-molecular-weight heparin. Kher A; Bauersachs R; Nielsen JD Thromb Haemost; 2007 Apr; 97(4):505-13. PubMed ID: 17393011 [TBL] [Abstract][Full Text] [Related]
34. Prevention of deep venous thrombosis and pulmonary embolism in patients with acute intracerebral hemorrhage. Orken DN; Kenangil G; Ozkurt H; Guner C; Gundogdu L; Basak M; Forta H Neurologist; 2009 Nov; 15(6):329-31. PubMed ID: 19901711 [TBL] [Abstract][Full Text] [Related]
35. A multicenter randomized double-blind study of enoxaparin compared with unfractionated heparin in the prevention of venous thromboembolic disease in elderly in-patients bedridden for an acute medical illness. The Enoxaparin in Medicine Study Group. Bergmann JF; Neuhart E Thromb Haemost; 1996 Oct; 76(4):529-34. PubMed ID: 8902991 [TBL] [Abstract][Full Text] [Related]
36. Fixed dose subcutaneous low molecular weight heparins versus adjusted dose unfractionated heparin for the initial treatment of venous thromboembolism. Robertson L; Jones LE Cochrane Database Syst Rev; 2017 Feb; 2(2):CD001100. PubMed ID: 28182249 [TBL] [Abstract][Full Text] [Related]
37. Prophylaxis strategies for patients with acute venous thromboembolism. Tapson VF Am J Manag Care; 2001 Nov; 7(17 Suppl):S524-31; discussion S531-4. PubMed ID: 11732663 [TBL] [Abstract][Full Text] [Related]
38. Fondaparinux: new preparation. No better than LMWH in preventing pulmonary embolism. Prescrire Int; 2003 Feb; 12(63):3-5. PubMed ID: 12602371 [TBL] [Abstract][Full Text] [Related]
39. Treatment of venous thromboembolism: adherence to guidelines and impact of physician knowledge, attitudes, and beliefs. Caprini JA; Tapson VF; Hyers TM; Waldo AL; Wittkowsky AK; Friedman R; Colgan KJ; Shillington AC; J Vasc Surg; 2005 Oct; 42(4):726-33. PubMed ID: 16242561 [TBL] [Abstract][Full Text] [Related]
40. Prevention of central venous catheter-associated thrombosis: a meta-analysis. Kirkpatrick A; Rathbun S; Whitsett T; Raskob G Am J Med; 2007 Oct; 120(10):901.e1-13. PubMed ID: 17904462 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]